Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Does Cardioversion of Atrial Fibrillation Increase the Risk of Stroke and Silent Cerebrovascular Thromboembolism? Comparison of the Two Cardioversion Methods

NCT01924065 is registered in ClinicalTrials.gov with Suleyman Demirel University as lead sponsor.

NCT NCT01924065
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01924065 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Does Cardioversion of Atrial Fibrillation Increase the Risk of Stroke and Silent Cerebrovascular Thromboembolism? Comparison of the Two Cardioversion Methods
Lead sponsor
Suleyman Demirel University
Phase
Phase 3
Overall status
Completed
Start date
August 31, 2013
Completion date
October 29, 2024
Enrollment
112 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation, cardioversion, cerebrovascular stroke